QUOTED. 27 November 2020. Agam Sharda.
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
“If you can give a high enough [radiation] dose to a tumor, you could kill it. The problem is the side effects and the rest of the body that cannot handle all this dose – you can kill the cancer, but you kill a whole lot of other stuff as well. The fact that Flash can help to preserve healthy tissue or to reduce side effects by up to 50% [is] really exciting, because you can now start to think about giving more dose to a cancer without having to damage healthy tissue.” – Agum Sharda, senior director of Flash, Varian
- Find out more: Varian Launches Trial Of Flash Ultra-High Dose Radiotherapy
Click here for a free trial of Medtech Insight